Allergan Implant Cancer Lawyer

Medical professional holding textured implant

In the summer of 2019, Allergan recalled its BIOCELL textured breast implants and tissue expanders after the U.S. Food and Drug Administration (FDA) received 359 reports of women developing cancer after receiving these implants. If you or someone you love has been diagnosed with breast implant associated anaplastic large cell lymphoma (BIA-ALCL), whether the implants were manufactured by Allergan or another company, you may be eligible to seek compensation through an Allergan implant cancer lawsuit.

Our licensed defective product lawyers are here to review your claim in a free, no-obligation consultation and determine if you have a valid case. We have recovered millions in verdicts and settlements for our clients, including $23 million in a defective product case. Jeff Phillips, our founding partner, works with other attorneys throughout the country to represent victims of defective products and is a Leaders Forum member of the American Association for Justice.

We accept defective product cases on contingency, so if we represent you, there are no upfront expenses. Our attorneys do not receive payment unless you receive compensation.

Call us today to discuss your injuries. 602-222-2222

Do I Have a Case?

At Phillips Law Group, our trusted lawyers welcome the opportunity to answer your questions. In a free consultation, we can learn more of the specifics of your claim so we can determine if you may have grounds for legal action.

If you or a loved one received BIOCELL breast implants manufactured by Allergan or another manufacturer and have recently been diagnosed with cancer, or are experiencing early signs of the disease, you may be eligible to file an Allergan implant cancer lawsuit.

Call us today at 602-222-2222 to schedule your free consultation and learn about your legal options.

What is My Case Worth?

Each case is unique, but if you are eligible to pursue damages and you hire our firm, we may be able to seek compensation against the BIOCELL breast implant manufacturer for the following:

  • Medical bills ”“ This may include compensation for the removal of your implants, diagnostic testing, and radiation therapy or other cancer intervention required to treat the BIA-ALCL.
  • Loss of wages ”“ Damages covered may include compensation for any wages lost resulting from your diagnosis and resulting treatment for BIA-ALCL.
  • Pain and suffering ”“ This compensation is provided to an injured victim for the actual physical pain and accompanying mental suffering experienced as a direct result of an accident or illness.

We can answer your questions in a free consultation.

Research on Links Between Allergan Implants and Cancer

2019 was not the first time the FDA reported a link between breast implants and BIA-ALCL. In 2011, the FDA identified a potential link, but it lacked enough evidence to prove a strong connection.

However, over the next several years, the FDA received hundreds of reports of women who had Allergan’s textured breast implants developing this type of cancer. Nine of the 359 women who filed medical device reports with the FDA died from their cancer.

In 2017, the FDA released a statement noting it agreed with the World Health Organization that BIA-ALCL is a type of lymphoma that can develop after receiving breast implants. The FDA also said it was going to continue monitoring medical device reports and reviewing research and data from the patient registry for breast implants and anaplastic large cell lymphoma.

One study the FDA looked at came out in 2017 and revealed the risk of ALCL among women with textured breast implants was 67.6 times higher than it was for women in the general population.

Based on this study and other research, the FDA acknowledged a low, but increased risk of ALCL for women with breast implants compared to those who did not have breast implants.

Allergan Recall

The FDA’s view of Allergan textured implants changed after it analyzed a worldwide report of 573 cases of BIA-ALCL. The report showed 481 of these patients had Allergan breast implants when they were diagnosed. Also, 12 of the 13 patients who died from their cancer had Allergan breast implants.

The FDA’s analysis of the data found people with these implants were six times more likely to develop BIA-ALCL than patients with textured implants from other manufacturers. This led to the FDA requesting that Allergan do a worldwide recall of all of its BIOCELL textured breast implants and tissue expanders on July 24, 2019. The FDA announced another recall on September 12, 2019. This was a Class I global recall of Allergan Natrelle BIOCELL textured products, including saline and silicone breast implants plus tissue expander. The FDA took this step ”“ the most serious type of recall ”“ because all the implants had not been accounted for.

In the recall announcement, the FDA said it would continue to evaluate new information about the link between BIA-ALCL and breast implants and may take action against other implant manufacturers.

Call our attorneys today to discuss a potential Allergan breast implant cancer lawsuit. 602-222-2222

FDA Recommendations for Those with Allergan Implants

The FDA’s recall announcement also included several recommendations for those who have Allergan BIOCELL breast implants.

The FDA recommends learning about the symptoms of BIA-ALCL, which may not appear for several years after receiving the implants. Common symptoms of this form of cancer can include:

  • Pain
  • Redness
  • Sudden swelling
  • Atypical asymmetry (unequal, out-of-the-ordinary changes to breast size)
  • Unexplained rash
  • Fluid build-up
  • Lump in the breast or armpit area
  • Breast encapsulation

As of the beginning of 2020, there were approximately 733 cases of BIA-ALCL associated with textured implants, along with 36 deaths. Of these 733 cases, 620 involved Allergan implants, according to the FDA. Of the reports of 36 deaths, 15 were patients who had an Allergan breast implant at the time they were diagnosed with BIA-ALCL.

If you develop any of these symptoms, the FDA recommends talking to your health care provider. If your doctor thinks you may have BIA-ALCL, he or she may order a physical exam, imaging or assessment of the fluid or tissue around your breast implants.

The FDA says patients who have a confirmed diagnosis should have the implants removed, along with the surrounding scar capsule.

Recent Allergan Implant Cancer Lawsuits

Allergan is facing numerous lawsuits in the U.S. and Canada over its textured breast implants. Many of the lawsuits filed in the U.S. have been condensed into federal multi-jurisdictional litigation (MDL). As of October 15, 2021, this MDL contained 904 legal actions. Cases are consolidated into an MDL when they have common facts and make similar allegations. Some of the allegations in these cases include:

  • Purposely concealing proof of increased risk for cancer associated with textured implants
  • Failure to warn both patients and medical professionals about the risks
  • Negligence
  • Promoting a product that was known to be defective

The MDL for Allergan breast implants is being managed by a federal district court in New Jersey.

If you or a loved one received textured implants and are experiencing any cancer symptoms, contact our office for a free consultation for a review of your claim and to discuss your possible legal options.

Contact a Phillips Law Group Attorney for More Information Today

If you or someone you love has received textured implants, either from Allergan or another manufacturer, and you have been diagnosed with BIA-ALCL or are suffering other side effects, we encourage you to contact our offices today.

The injury lawyers at our firm have more than two decades of experience representing injury victims. We have a history of proven results and have recovered millions in verdicts and settlements.

Contact us today to schedule your confidential and free consultation. We can review your claim and answer your questions about how a class action lawsuit works and what you may expect if we represent you. We accept defective product cases on contingency, so there are no out-of-pocket costs charged to you up front. If we do not win compensation on your behalf, we do not get paid.

Our office in Phoenix is about 10 minutes from Banner MD Anderson Cancer Center.

Call us now at 602-222-2222 . You can reach us 24 hours per day, seven days per week.